Healthcare US Clinical Decision Support System (CDSS) Growth Opportunities Updated Research Available

Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey

INDUSTRY
Healthcare

RELEASE DATE
08-Mar-2022
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K711-01-00-00-00
SKU
HC03517-NA-MT_26361
Yes
SHARE

US Clinical Decision Support System (CDSS) Growth Opportunities
Published on: 08-Mar-2022 | SKU: HC03517-NA-MT_26361

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform.

This report reviews the growth opportunities that are driving the US CDSS market. It provides the current market segmentation that includes a mix of established content-based solutions and technical companies that are attracted to the CDSS space. The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.

Research Scope

For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the US CDSS Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Executive Summary

Scope of Analysis

Segmentation

Key Growth Metrics

Key Competitors

Growth Drivers

Growth Driver Analysis

Growth Driver Analysis (continued)

Growth Restraints

Growth Restraint Analysis

Growth Restraint Analysis (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Application

Revenue Forecast Analysis

Competitive Environment

CDSS Market—Mergers & Acquisitions

CDSS Market—Mergers & Acquisitions (continued)

Key Growth Metrics

Revenue Forecast

Revenue Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Case Study—Change Healthcare, a Payer/Provider Ecosystem

Case Study—Wolters Kluwer, Building an End-to-End Solution in a Patient-centric Model

Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions

Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions (continued)

Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery

Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery (continued)

Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics

Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

List of Figures
  • CDSS Market: Key Growth Metrics, US, 2021
  • CDSS Market: Growth Drivers, US, 2022–2026
  • CDSS Market: Growth Restraints, US, 2022–2026
  • CDSS Market: Revenue Forecast, US, 2021–2026
  • CDSS Market: Revenue Forecast by Application, US, 2021–2026
  • CDSS Market: Competitive Environment, US, 2021
  • CDSS Market: Key Acquisitions, US, 2021–2022
  • Decision Evidence Segment: Key Growth Metrics, US, 2021
  • Decision Evidence Segment: Revenue Forecast, US, 2021–2026
  • Decision Analytics Segment: Key Growth Metrics, US, 2021
  • Decision Analytics Segment: Revenue Forecast, US, 2021–2026
  • Decision Workflow Segment: Key Growth Metrics, US, 2021
  • Decision Workflow Segment: Revenue Forecast, US, 2021–2026
  • Decision Delivery Segment: Key Growth Metrics, US, 2021
  • Decision Delivery Segment: Revenue Forecast, US, 2021–2026

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Digital Health research

06 Oct 2026   |   Global   |   Technology Research

Trends in Laboratory Automation, Global, 2021–2025

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, inte...

21 Sep 2026   |   Europe   |   Market Research

HLTH Europe 2026: Five Key Takeaways and Growth Opportunities

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...

21 Sep 2026   |   Global   |   Frost Radar

Frost Radar: Smart Nutraceuticals for Brain Health, 2026

This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...

18 Sep 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metaboli...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This report reviews the growth opportunities that are driving the US CDSS market. It provides the current market segmentation that includes a mix of established content-based solutions and technical companies that are attracted to the CDSS space. The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.--BEGIN PROMO--

Research Scope

For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.

More Information
Deliverable Type Market Research
No Index No
Podcast No
List of Charts and Figures CDSS Market: Key Growth Metrics, US, 2021~ CDSS Market: Growth Drivers, US, 2022–2026~ CDSS Market: Growth Restraints, US, 2022–2026~ CDSS Market: Revenue Forecast, US, 2021–2026~ CDSS Market: Revenue Forecast by Application, US, 2021–2026~ CDSS Market: Competitive Environment, US, 2021~ CDSS Market: Key Acquisitions, US, 2021–2022~ Decision Evidence Segment: Key Growth Metrics, US, 2021~ Decision Evidence Segment: Revenue Forecast, US, 2021–2026~ Decision Analytics Segment: Key Growth Metrics, US, 2021~ Decision Analytics Segment: Revenue Forecast, US, 2021–2026~ Decision Workflow Segment: Key Growth Metrics, US, 2021~ Decision Workflow Segment: Revenue Forecast, US, 2021–2026~ Decision Delivery Segment: Key Growth Metrics, US, 2021~ Decision Delivery Segment: Revenue Forecast, US, 2021–2026~
Author Delfina Huergo
Industries Healthcare
WIP Number K711-01-00-00-00
Keyword 1 CDSS
Keyword 2 Clinical decision support (CDS)
Keyword 3 electronic health records (EHRs)
Is Prebook No
GPS Codes 9564-B1,9600-B1,9612-B1

US Clinical Decision Support System (CDSS) Growth Opportunities

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03517-NA-MT_26361